Results 1 to 10 of about 4,538 (185)
Medication-related osteonecrosis of the jaw: Prosthodontic considerations
Japanese Dental Science Review, 2022 Medication-related osteonecrosis of the jaw (MRONJ) can be triggered by several antiresorptive and antiangiogenic medications, including bisphosphonates (BRONJ), denosumab (DRONJ), and other agents used to treat osteoporosis and metastatic bone cancer ...
Islam Harb, Yuka I Sumita
exaly +5 more sources
Japanese Dental Science Review, 2019 Summary: Since Marx reported on osteonecrosis of the jaw caused by the injectable bisphosphonates (BPs) pamidronate and zoledronate, there have been numerous reports not only in Western countries, but in Japan as well, of bisphosphonate-related ...
Takahiko Shibahara
exaly +3 more sources
Adalimumab: Another Medication Related to Osteonecrosis of the Jaws? [PDF]
Case Reports in Dentistry, 2016 Objective. The acronym MRONJ has been created in order to identify “Medication-Related Osteonecrosis of the Jaw,” observed after the use of Bisphosphonates, RANK ligand inhibitor, and antiangiogenic medications. Only a case of osteonecrosis of the jaw in
Andrea Cassoni +8 more
doaj +4 more sources
Medication-Related Osteonecrosis of the Jaw—A Continuing Issue [PDF]
Applied Sciences, 2021 Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is a condition that is becoming more common in the everyday practice of both dental and maxillofacial surgeons.
Krzysztof Wróbel +4 more
doaj +2 more sources
MicroRNA in medication related osteonecrosis of the jaw: a review
Frontiers in Physiology, 2023 Medication related osteonecrosis of the jaw (MRONJ) is a condition caused by inhibition of the osteoclast activity by the anti-resorptive and anti-angiogenic drugs.
Siti Salmiah Mohd Yunus +5 more
doaj +3 more sources
Brazilian Journal of Otorhinolaryngology, 2022 Introduction: Increased incidence of localized osteonecrosis in the jaw bones caused by bisphosphanate use and reduced quality of life of the patients led researchers to diagnose the disease in the early period and to investigate the effective treatment ...
Onur Şahin +5 more
doaj +1 more source
Medication-Related Osteonecrosis: Why the Jawbone?
Dentistry Journal, 2023 Medication-related osteonecrosis of the jaw (MRONJ) has emerged as a complication of anti-resorptive medications. Despite its low incidence rate, this problem has gained attention in recent years due to its devastating consequences and lack of preventive
Sydney Kuehn +2 more
doaj +1 more source
Applied Sciences, 2022 Osteonecrosis of the jaw represents interference by external and internal factors in the natural bone remodeling system. Numerous bone remodeling agents (BMAs), such as bisphosphonates, denosumab, and tyrosine kinase inhibitors, can lead to medication ...
Mihai Vlad Golu +6 more
doaj +1 more source
Medication-related Osteonecrosis of the Jaw: A Review [PDF]
Cureus, 2020 Medication-related osteonecrosis of the jaw (MRONJ) is a rare, severe debilitating condition from unknown causes. It is characterized by nonhealing exposed bone in a patient with a history of antiresorptive or antiangiogenic agents in the absence of radiation exposure to the head and neck region. The first case of MRONJ was reported in the early 2000s.
AlDhalaan, Nouf A +2 more
openaire +2 more sources
BMC Oral Health, 2021 Background Accurate documentation of a patient’s prior medication use and awareness of side effects associated with anti-osteoporotic agents can assist dentists to prevent medication-related osteonecrosis of the jaw. I aimed to determine the awareness of
A. Lum Han
doaj +1 more source